Novo Nordisk Beating Lilly in Obesity Pill Market: What It Means for Investors
Novo Nordisk is gaining ground on Lilly in the obesity pill market. This article breaks down the drivers, the competi...
Which Sp 500 ETF Has The Lowest Fees 2024 helps identify the most affordable option. Evaluate fees, liquidity, and track record for smart choices.
27,739 articlesNovo Nordisk is gaining ground on Lilly in the obesity pill market. This article breaks down the drivers, the competi...
Palo Alto Networks has surged about a month’s worth of gains, fueling a debate on whether to book profits and rotate ...
A little-known aerospace stock has delivered a blistering 470% gain over five years and recently reached a fresh all-...
Lam Research has quietly outpaced rivals in AI tooling, delivering triple-digit gains as 2026 guidance stays upbeat. ...
A growth stock that surged to lofty heights last year has cooled in 2026, but big buyers keep stepping in as AI capac...
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
A smaller biotech is stealing headlines in 2026 by delivering strong trial results and strategic collaborations. This...
A top tech stock faces a likely pullback in the second half of 2026 as demand shifts and costs rise. Traders should h...
Two Harbors moved its special meeting to July 2 to push the CrossCountry Mortgage deal through, while a rival bid fro...
At midyear 2026, JPMorgan’s top three overweight picks show a split: one stock has cleared its upside target, while t...
Eli Lilly has powered higher for years, delivering eye-popping gains. But is there more room to run, or is it time to...
Warren Buffett’s transition at Berkshire Hathaway ushers in a new era. Yet three longtime favorites—Apple, American E...